Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

A nonprofit incubator said it will take over a 33,000-square-foot building in Richmond, which also possesses manufacturing ...

Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...